retatrutide effects clinical trials Retatrutide, an experimental drug currently in Phase 3 trials, is nicknamed the Godzilla of weight-loss jabs because of its potential superior efficacy. Developed by Eli Lilly, is a triple hormone This Triple Action Peptide is

Likely yes

it's a consistent, week-over-week reduction

For patients taking tirzepatide, adherence to prescribed dosing, attention to nutrition despite reduced appetite, adequate hydration, and regular follow-up are more important than supplementation

By mimicking the action of these naturally occurring incretin hormones, tirzepatide helps regulate blood glucose levels, reduces appetite, and slows gastric emptying, leading to improved glycaemic control and weight loss

Use outside major metros grew 4.2 between 2025 and 2029

They cannot claim to deliver the same outcomes as FDA-approved GLP-1 drugs like Wegovy or Zepbound, Ventura tells TODAY.com